Activated DCs also present the tumor antigens, culminating mainly in the activation of CD8+ cytotoxic T lymphocytes, which are fundamental in the activation of the tumor retraction immune antitumor response [33,43]. The gene discussed is CD8A; the disease is neoplasm.